Alexander Tsiskaridze

Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial

James F. Howard, Vera Bril, Tuan Vu et al. · The Lancet Neurology · 2021 · 587 citations · Full text

Medicine, Generalised Myasthenia Gravis

Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study

Vera Bril, Artur Drużdż, Julian Großkreutz et al. · The Lancet Neurology · 2023 · 227 citations

Clinical Trials, Generalised Myasthenia Gravis, Pharmacotherapy +3

The state of stroke services across the globe: Report of World Stroke Organization–World Health Organization surveys

Mayowa Owolabi, Amanda G. Thrift, Sheila Cristina Ouriques Martins et al. · International Journal of Stroke · 2021 · 180 citations · Full text

Global Impact of COVID-19 on Stroke Care and IV Thrombolysis

Raul G. Nogueira, Muhammad M. Qureshi, Mohamad Abdalkader et al. · Neurology · 2021 · 151 citations · Full text

Global impact of COVID-19 on stroke care

Raul G. Nogueira, Mohamad Abdalkader, Muhammed M. Qureshi et al. · International Journal of Stroke · 2021 · 147 citations · Full text